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ABSTRACT
￿
The adenylate cyclase of C6 glioma cell cultures was characterized for sensitivity to
the ,ß-adrenergic agonist isoproterenol, as well as fluoride, and GTP as a function of the cell
cycle . The mitotic phase of the cell cycle was emphasized because both the basal cellular cyclic
AMP level and the intact C6 cell's capacity to accumulate cyclic AMP in response to isoproter-
enol decreased during mitosis . Basal and stimulated adenylate cyclase activities in mitotic cells
were decreased relative to the enzyme activities in the G,, S, and G2 phases of the cell cycle .
Analysis of the,8-adrenergic receptor using the radioligand (-) [3H]dihydroalprenolol showed
that neither ligand affinity nor receptor density changed during the cell cycle, indicating that
the reduced adenylate cyclase activity of the mitotic C6 cell was not caused by alterations in
this hormone receptor . The reduction in the mitotic cell's basal adenylate cyclase activity was
more prominent than the decrease in isoproterenol-, fluoride, or GTP-stimulated activities,
suggesting that the effectiveness of these enzyme activators (i.e ., the efficiency of the coupling
mechanism) was not attenuated during mitosis . These studies indicate that the intrinsic catalytic
capacity (not the,t8-adrenergic receptor or the coupling mechanism) of the C6 adenylate cyclase
complex is reduced during mitosis and contributes to the mitotic cell's inability to accumulate
and maintain the cyclic AMP concentration at the interphase level .
Intracellular levels ofcyclicAMPdecrease as cells enter mitosis
and then rapidly increase as cells complete mitosis and enter
the G, phase of the cell cycle (5, 26, 36, 39, 44, 45) . To correlate
the observed changes in intracellular cyclic AMP levels with
cyclic AMP synthesis and hydrolysis, we examined adenylate
cyclase (EC 4.6 .1 .1 .) and phosphodiesterase (EC 3.1.4.17.) en-
zyme activities in synchronized cells . Sodium fluoride or hor-
mone-stimulated adenylate cyclase activity generally was ob-
served to be lower in enzyme preparations from mitotic cells
than in those from cells within otherphases (G ,, S, G2)' of the
division cycle (14, 26, 28) . However, basal adenylate cyclase
'Abbreviations usedin thispaper: DMEM, Dulbecco's modified Eagle's
medium ; FMF, flow microfluorimetry ; G, phase, the period after the
completion of mitosis and before the initiation ofDNA synthesis; G2
phase, the period after the S phase and before mitosis; [3H]DNA,
(-)[3Hldihydroalprenolol;Mphase, mitosis; MSH, melanocyte-stimu-
lating hormone; PBS-CM, Dulbecco's phosphate-buffered saline sup-
plemented with Ca" and Mg'2; PBS-CMF, Dulbecco's phosphate-
buffered saline without Ca" or Mg"; S phase, the period ofDNA
replication in proliferating cells .
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activity increased linearly as cells progressed from early G, to
the next mitosis (14, 28) . Cyclic AMP phosphodiesterase activ-
ity was found to increase during mitosis coincident with a
decline in adenylate cyclase activity (26) . An efflux of cyclic
AMPduring mitosis has also been observed (44).
These previous studies did not correlate cell cycle-specific
alterations in theadenylate cyclase activity with changes in the
intact cell's capacity to accumulate cyclic AMP. In the most
complete study reported, both basal and hormone-elevated
levels of cellular cyclic AMP were assayed during the cell cycle
using synchronized Cloudman melanoma cells (42) . These
studies demonstrated that an increased density ofmelanocyte-
stimulating hormone (MSH) receptors in G2 was associated
with a G2 phase-specific sensitivity to MSH (41, 42) . However,
because adenylate cyclase enzyme activity was not measured,
a correlation could not be made between the cellular cyclic
AMP level and the enzyme activity . Thus, a thorough exami-
nation and comparison of the cell cycle phase-dependent
changes in cyclic AMP levels, adenylate cyclase specific activ-
ities, and hormone receptor characteristics has yet to be per-
formed on a single experimental system .
169We chose the C6 glioma cell line for this particular study
because it is responsive to physiological concentrations of ß-
adrenergic agonists such as isoproterenol (13). Membranes
prepared from these cells possess both a ß-adrenergic-sensitive
adenylate cyclase activity (4, 13, 20) and measurable ß-adre-
nergic receptor-binding sites for the radiolabeled antagonist
(-) [3Hidihydroalprenolol ([3HIDHA) (20, 21). The C6cell line
seemed especially suited as a model for assaying these activities
during the cell cycle because of its apparent tight "coupling"
between occupancy of the (3-adrenergic receptor site by an
agonist molecule and the subsequent activation of the adenyl-
ate cyclase moiety (21). We chose to focus on the interval of
the cell cycle immediately before and after mitosis because of
the suggested importance of cyclic AMP during mitotic events
(5, 39).
In this communication we present evidence that both the
basal cyclic AMP levels and the accumulation of cyclic AMP
in response to the iß-adrenergic agonist isoproterenol are de-
pressed in mitotic C6 cells relative to cells synthesizing DNA,
cells in GZ, or cells in early Gr. Furthermore, both basal and
stimulated adenylate cyclase-specific activities, but neither
['HIDHA binding site affinity nor density, decrease coincident
with intact cell changes in mitosis. Surprisingly, there was an
increase in the mitotic cell's stimulation index, which is calcu-
lated by dividing the effector-augmented adenylate cyclase
activity by the basal enzyme activity.
MATERIALS AND METHODS
Cell Culture
Cultures of Cs cells were grown in Dulbecco's modified Eagle's medium
(DMEM) supplemented with 2 MM t.-glutamine and 10% fetal calf serum (the
growth medium) in the absence ofantibiotics. Thefetalcalfserum was incubated
before use for 18 h at 37'C to hydrolyze serum cyclic AMPand then heat treated
at 56oC for 30 min to inactivate complement and phosphodiesterase activities.
Cells were maintained at 37'C in a 1070 COZ-90%, air, humidified atmosphere.
Cell cultures were judged free of mycoplasma contamination by both measure-
ment of [''H]uridine/[sH]uracil incorporation (35) and scanning electron micros-
copy.
Broken Cell Preparations
The growth medium was removed and the culture plates were rinsed twice
with 10 ml of ice-cold Dulbecco's phosphate-buffered saline without Ca" or
Mg` (PBS-CMF) and drained well. Subsequent steps were performed at 4°C.
Thecells were quickly rinsed with 5 ml of 50 mM Tris-HCI, pH 7.4, at 4°C, and
the cells scraped from the plates into a chilled tube in 10 mM Tris-HCI, pH 8.0,
at 4°Cand allowed to swell for 10 min. Theenlarged cells were homogenized in
a tight-fitting 10-ml glass-Teflon Potter Elvehjetn-type tissue grinder by five slow
strokes. After at least 90% of the cells were ruptured, the homogenate was used
immediately for the determination ofadenylate cyclase activity.
Membranes from Cs cells to be used for characterizing the ß-adrenoreceptor
binding sites were prepared by bringing the homogenate to 1 mM Mg". The
intact cells and nuclei then were removed by centrifugation for 5 min at 1,200
rpm in a Sorvall HL-4 rotor (DuPont Instruments-Sorvall, DuPont Co., New-
town, Conn.) (max =200 g). Thesupernate was then centrifuged in a Sorvall SS
34 rotor (max =30,000 g) for 20 min. Thepellet was rinsed with l ml of 10 mM
Tris-HCI and resuspended in a suitable volume of 10 mM Tris-HCI with two
strokes of the homogenizer.
Adenylate Cyclase Assay
The final concentration of the components used in the standard adenylate
cyclase reaction mixture were: 80 mM Tris-maleate, pH 8.3, at 30°C, 1 mM ATP,
10 MM M9C12, 1.0 mM theophylline, and a nucleotide-regenerating system
consisting of 40 fig (24 U) of pyruvate knase, 2.5 mM phospho(enol)pyruvate,
and 5 mM KCI, in a final volume of 500 pl. Test agents, when used, were
included in this reaction volume.Thereaction was initiatedby the additionof50
Al ofenzyme preparation to the assay tubes, which had been preequilibrated to
30°C for at least three minin a shaking water bath. After incubation for exactly
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10 min, the reaction was terminated in a boiling water bath for 3 min. Thetube
was then placed in an ice-water bath. Experimental blanks were boiled upon
lysate addition without prior incubation to assess the effect of additives on the
cyclic AMP-binding assay and to detect any endogenous cyclic AMP. All the
boiled samples were centrifuged at 1,000 x g for 20 minbefore aliquots of the
supernate were assayed, with or without dilution, for cyclic AMPcontent.
Under these conditions the basal and stimulated adenylate cyclase activities
were linear for protein concentration (30-200Iug) and linear for at least 10 minof
incubation at 30°C. Better than 85% of the cyclic AMPgenerated was preserved
underthese conditions. The activity ofadenylate cyclase is reported as picomoles
ofcyclic AMPformed per minute per milligram protein determined during a 10-
min incubation.
Cyclic AMPAnalysis
This was modified from the method of Brown et al. (3). Protein kinase was
prepared from bovine adrenal glands and was purified using the procedure
described in reference 3. Cyclic AMPvalues were obtained by the linear regres-
sion analysis ofstandard curves constructed from the log ofthe bound ["H]cyclic
AMP(cpm) as a function of the log of the total picomoles of unlabeled cyclic
AMP. The coefficient of variation of this competitive binding assay was t4%.
Incubation of a sample with cyclic nucleotide phosphodiesterase eliminated 90-
100% of the competition between an unknown and ["H]cyclic AMP for the
binding protein.
Cyclic AMP Content of Intact Cells
Intact cell experiments were conducted in a 37'C warm room. Cells on 35-,
60-, or 100-mm culture plates were kept in a 37'C cell culture incubator until
they were used. Culture medium was removed with a vacuum pump-aspirator
assembly andthe cellswere quickly rinsedwith two 1.8-ml volumesofDulbecco's
phosphate-buffered saline supplemented with Ca` and Mg'. ' (PBS-CM). The
basal cyclic AMPlevel wasdetermined after the addition of 1.0 ml of 5% TCA
at 4°C. Alternatively, to examine the effects of ß-adrenergic agonists on intracel-
lular cyclic AMPlevels, we added PBS-CM with the phosphodiesterase inhibitor
Ro 20-1724to cover the cells (1.8 ml). Within 30 s the incubation with or without
ß-adrenergic agonist and/or antagonist was begun. After an appropriate incu-
bation time the buffer was removed and 1.0 ml of cold 5% TCA was added to
extract the cyclic AMP. Theplates were then kept at 4oC for -30 min. TCAwas
removed from the cell extract by ether extraction. Cyclic AMPwas measured as
described above.
(-) [ 3HJDHA Binding to
Membrane Preparations
Theassay ofthe [''H]DHA specific binding sites ofCfi cells utilized a reaction
mixture identical to that ofthe adenylate cyclase assay. The reaction wasinitiated
by the addition ofthe membrane protein (30-100 pg ofprotein) to the otherwise
complete mixture (in polystyrene tubes), giving a final volume of 100 pl. The
binding was allowed to proceed for 13-I8 minat 30'C in a shaking water bath.
To end the binding reaction, the contents of the tube were diluted with I ml of
ice-cold 50 mM Tris-HCI, 20 mM MgC12, pH 8 at 0°C (buffer A) and rapidly
poured over a glass fiber GF/c filter held in a Millipore rapid-sampling vacuum
manifold (Millipore Corp., Bedford, Mass.). The tube was then washed with
another 4 ml ofbuffer A.
After the filtration of all the incubation tubes, the vacuum was increased to
remove trapped water containing ["H]DHA. The filters were then placed in
scintillation vials and mixed in toluene-based scintillation cocktail (90% toluene,
10% vol/vol Biosolv BBS-3, and 0.4% vol/vol 2a70). The membrane-bound
[''H]DHA was determined in a Beckman scintillation counter (35% efficiency)
after the filters had clarified (-2 h later). Under these conditions the steady-state
association of 10 nM ['HIDHA was attained within l min and remained constant
for at least 20 min. Binding was proportional to the membrane concentration,
was saturable, and could be reversed by the addition of unlabeled alprenolol or
propranolol. Specific binding was defined as the difference in ["H]DHA bound
in the presence andabsenceof 10-'M (-) alprenolol (unlabeled), each performed
in triplicate. Nonspecific binding (that ['HIDHA bound in the presence of
unlabeled [-] alprenolol) was independent of incubation time and dependent
on ['HIDHA concentration. Scatchard analysis (31) of specific binding data
was utilized to determine the binding capacity and KD (dissociation constant) of
['HIDHA of cell lysates.
Cell Synchronization
Flasks of stock cells were trypsinized and diluted in the proper volume of
medium such that there were 20-30 x 10" cells/cm' of surface area and, 24 h
later, the first of two thymidine blockades commenced.Cellswere exposed to 0.1 mM thymidine in growth medium for- 17 h, washed
free of thymidine, and incubated for -11 h, incubated in 1 mM thymidine for an
additional 13 h, and again rinsed free of thymidine . Such exposure to I mM
thymidine had no effect on the ability of the C s cell population to resume
proliferation (detected by the incorporation of [''Hlthymidine during a 20-h
labeling period) compared to unsynchronized cultures ; the labeling indices were
91 and 94%, respectively. After the release from the second thymidine block, cells
were allowed to progress into S phase for -4 h . Sterile colcemid (in growth
medium) was added to give a final concentration of 0.05 lig/ml (0.13 ftM). The
incubation was continued for 6 h, allowing an accumulation of up to 70% of the
cells in mitosis (late prophase) . The colcemid blockade was ended by rinsing the
cells two times with DMEM and adding complete growth medium . I h later the
medium was replaced with fresh growth medium . Less than 5% of the cells
remained in mitosis after 1 h in colcemid-freemedium.
The mitotic index (MI ; cells in late prophase to early telophase) was deter-
minedon ethanol-glacial acetic acid- (7 :3) fixed cells by counting 400-600 cells
using a phase microscope fitted with an ocular grid . The number of cells per
culture plate was assessed by counting the trypsinized cultures either with the
flow microfluorimeter or in a hemocytometer. Duplicate plates were assayed .
Cultures were labeled with [''Hlthymidine, fixed, and processed for autoradiog-
raphy by standard methods (2) . These techniques, along with flow microfluori-
metry(FMF), were used duringan experiment to analyze the extent and duration
ofthe synchronyand the rate at which the cells progressed through the cell cycle .
Materials
The established glioma cell line Cs was obtained from the American Type
Culture Collection . Fetal calf serum from Flow Laboratories Inc. (Rockville,
Md.) and L-glutamine (Grand Island Biological Co. [GIBCO], Grand Island,N .
Y .) were used to supplementDMEM from GIBCO . ATP, GTP, and cyclicAMP
were purchased from Sigma Chemical Co. (St. Louis, Mo.). [''Hlthymidine (30-60
Ci/mmol), [''HlcyclicAMP(40-60 Ci/mmol), [''HlcyclicAMP(40-60 Ci/mmol),
and (-) [''HIDHA HCl (40-60 Ci/mmol) were obtained from New England
Nuclear(Boston, Mass.). ATP, GTP, cyclicAMP, phospho(enol)pyruvate, bovine
3',5'-cyclic nucleotide phosphodiesterase, pyruvate kinase, L-isoproterenol HCI,
L-epinephrine, and L-norepinephrine HCI were purchased from Sigma Chemical
Co . L-propranolol HCIand D-propranolol HCI came from Ayerst Laboratories
(New York), and D-isoproterenol-D-bitartrate was purchased from Hassel Prod-
ucts, Inc. (Bellport, N. Y.). Norit SG Extra charcoal was purchased from J . T .
Baker Chemical Co. (Phillipsburg, N. J.) . Whatman GF/C filters were used .
Beckman Instruments, Inc . (Fullerton, Calif .) manufactures Biosoly BBS-3, and
2a70 was purchased from Research Products International Corp . (Elk Grove
Village, Ill .) . Colcemid was obtained in lyophilized form from GIBCO . Calbi-
ochem-Behring Corp., American Hoechst Corp. (San Diego, Calif) supplied
propidium iodide. 4-(3-butoxy-4-methoxy)-2-imidazolidinone (Ro 20-1724) was
the gift of Dr. H . Sheppard, Hoffmann-LaRoche, Inc . (Nutley,N . J.).
RESULTS
Cyclic AMP Levels in Synchronized C6 Cultures
The basal intracellular level of cyclic AMP was measured
during the hours before and after mitosis (Fig . 1) . The mean
cyclicAMP levels ofcultures showed a significant and transient
decrease at a point coinciding with the peak mitotic index . As
the cell population entered G t , the amount of intracellular
cyclic AMP invariably increased to levels meeting or exceeding
those found before mitosis .
Responsiveness of Intact, Synchronized Cs Cells
to ß-Adrenergic Stimulation
(-) Isoproterenol (0 .1 AM) is capable of rapidly elevating the
intracellular level of cyclic AMP in cultured C B glioma cells
(13) . This catecholamine stimulation was more pronounced in
the presence of the phosphodiesterase inhibitor Ro-20-1724 (15
hg/ml), and was rapidly inhibited upon addition of the 8-
adrenergic antagonist (-) propranolol (not shown), consistent
with the stimulation of adenylate cyclase activity through the
iß-adrenoreceptor. The cyclic AMP accumulation in response
to 0 .1 AM (-) isoproterenol reached a maximum in ^-20 min
(5,000 pmol cyclic AMP/mg protein) of which the initial 3-
5 min were linear (data not shown) . Because it was desirable to
n
0
_2 E
U O
Q G U
0
ô
%0 d
U
Q
20
5
E
n
10
9
8
14
0
102
U
ca
6 ó
2 ó
I
￿
I
￿
I
￿
I
￿
I
7
￿
8
￿
9
￿
10
￿
II
Time, Hours after Release
Jo
FIGURE 1
￿
Basal cyclic AMP levels during the cell cycle . Basal cyclic
AMP was extracted from rinsed cultures with 5% TCA . The mean ±
SE of cyclic AMP levels is shown on the graph . Cell counts were by
the FMF technique. These results were representative of four differ-
ent synchrony experiments .
rapidly measure the (-) isoproterenol responsiveness of syn-
chronized C s cells before adenylate cyclase desensitization (8,
43) or cyclic AMP efflux (29) occurred, such cells were incu-
bated with hormone for only 2 min before the reaction was
terminated with TCA . The measured cyclic AMP was therefore
an indication of the initial rate or activity of adenylate cyclase
rather than of the total capacity of the C 6 cells to accumulate
cyclic AMP. Control studies using multiple cultures confirmed
that the experimental variability ofthe 2-min incubation period
was <I0°lo .
The accumulation of cyclic AMP during a 2-min exposure
to 0.1 AM (-)isoproterenol was measured in double thymidine
synchronized cells that had subsequently been treated with
0.13AM colcemid during mid-S phase . Experiments performed
to examine the effect ofcolcemid on cellular hormone response
showed that a concentration of colcemid (1 AM) eightfold
higher than that used for mitotic arrest (0.13 AM) had no
significant effect on the isoproterenol responsiveness of expo-
nentially growing CB cell cultures . This synchronization tech-
nique was employed for the intact cell hormone stimulation
studies as well as the subsequent analysis of adenylate cyclase
and [3HJDHA-binding activities . The varying responsiveness
of the cells to isoproterenol during the cell cycle is shown in
Fig. 2, which is a representative experiment using both high
and low density cultures . The mean cyclic AMP accumulation
in the higher density cultures remained constant during -5 h
before mitosis (regardless of the presence or absence of col-
cemid) until a significant decrease in sensitivity occurred at 11
h, the time of maximal accumulation of mitotic cells in this
experiment . Isoproterenol responsiveness increased after the
cells were released from mitotic arrest and had advanced into
the G t phase of the cell cycle . The low density cultures showed
similar changes but exhibited a more dramatic increase as the
cells advanced from M to the early G, phase .
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Cell Cycleand Adenylate Cyclase Activity
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FIGURE 2
￿
Effect of cell cycle traverse on isoproterenol stimulation
of intact cells . Cells were synchronized by double-thymidine block-
ade followed by colcemid addition 5 .5 h after removal of the
thymidine. The synchronized progression of cells through the cell
cycle was assessed by FMF (data not shown) and MI . (maximum =
48% at 11 h) . Cyclic AMP levels, after a 2-min stimulation of intact
cells by 0 .1 fiM (-)isoproterenol, were determined on three separate
cultures at each time point afterether extraction ofTCA as described
in Materials and Methods . Colcemid was removed at 11 h and the
cultures were incubated with isoproterenol 3 h later at 14 h (early
G, phase) . Cell densities were determined in late S phase: higher
density (" ) = 3 .5 x 108 cells/60-mm plate ; low density (O) 1 .3 x 10 6
cells/60-mm plate. Significant differences (Student's t test) were
observed between isoproterenol responsiveness in mitotic (11 h)
cultures and higher density cultures at 9 h ( P < 0.05) and at 14 h ( P
< 0.1) as well as lower density cultures at 9 h (P< 0.05) and at 14
h (P< 0.05) . The data from FMF analysis and MI determination were
used to determine the percentage of cells accumulated in mitosis .
The adenylate cyclase activity in homogenates of unsyn-
chronized C6 cells is maximally stimulated by 10 P.M GTP
(Fig. 3), with half-maximal stimulation of 0.5-1 AM GTP .
(-)Isoproterenol, another stimulator of adenylate cyclase activ-
ity (Fig. 3), was more effective than GTP alone and showed a
biphasic dependence on the GTP concentration . As in intact
C6 cells, isoproterenol stimulation of the adenylate cyclase
possessed the characteristics of a ß-adrenergic receptor : (-)ag-
onists were more effective cyclase stimulators than (+) agonists;
(-)propranolol prevented isoproterenol stimulation at a 100-
fold lower concentration than did (+)propranolol ; and (-)iso-
proterenol was an effective agonist at 5- to 10-fold lower
concentrations than was (-)epinephrine or (-)norepinephrine .
Sodium fluoride, the third activating agent which was used in
these cell cycle studies, stimulated the enzyme activity to about
the same degree as didGTP (compare Figs . 3 and 4) . However,
unlike GTP, NaF consistently inhibited the isoproternol stim-
ulation of adenylate cyclase (Fig . 4) . These results serve to
illustrate the difference in the action and interaction of these
agents on the C6 adenylate cyclase activity .
Adenylate cyclase activity was measured at three different
time points within the cell cycle : at approximately t = 6 h, 10
h, and 14 h, corresponding to the late S, M, and early G, phase,
respectively . Four different plates ofCe cultures (each yielding
separate homogenates) were assayed at each cell cycle time
point to measure cyclase activity (Table I) . In these experi-
ments, sodium fluoride, GTP, and isoproterenol were capable
of stimulating adenylate cyclase to activities 3- to 24-fold above
basal enzyme activity. It is evident (Table I) that the stimulated
adenylate cyclase enzyme decreased in specific activity as the
cells traversed the cell cycle from the latter part of the S phase
to mitosis . Moreover, homogenates from G, phase cells gener-
ally had significantly elevated specific activities relative to the
activities observed during mitosis. This is consistent with the
observations of reduced levels of basal cyclic AMP and the
decreased rate of cyclic AMP synthesis during incubation of
mitosis-enriched cells with isoproterenol. Although a combi-
nation ofGTP and isoproterenol increased the enzyme activity
observed in the synchronized cells (not shown), it did not
FIGURE 3 Effect of isoproterenol on GTP stimulation of the ade-
nylate cyclase activity Of C 6 homogenates . Incubation of homoge-
nates with either no hormone (") or 1 PM (-)isoproterenol (") in
the presence of different concentrations of GTP was performed in
standard cyclase assay conditions as described in Methods and
Materials . Different homogenates were used for each curve ; basal
activity (pmol cAMP/min " mg protein) was 20 (W and 22 (" ) .
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FIGURE 4
￿
Fluoride inhibitionof isoproterenol-stimulated adenylate
cyclase . Adenylate cyclase activity was determined in the presence
of fluoride alone (A), or fluoride plus the following isoproterenol
concentrations : 0 .1 fLM (O), 1 tLM ("), 10 JAM (O), 100 ILM (~ . The
cyclase assay conditions and detection of cyclic AMP were per-
formed as described in Materials and Methods .
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The adenylate cyclase activity in each culture dish was measured in duplicate using standard assay conditions . The activities are arranged within each column
as a mean value± SE for the number of dishes or observations in parentheses . All activities are expressed as pmol cyclic AMP formed/min -mg protein from a
10-min incubation . Within each experiment, adenylate cyclase activities were compared by Student's t test between S and M phases or between G, and M ;
asterisks by either S or G, activities indicate the statistical significance of the difference in relation to the M phase enzyme activity . These are data from one
representative synchrony experiment .
* P< 0.005 .
$ P< 0.01 .
§ Unsynchronized cultures .
reverse the decline in isoproterenol-stimulated specific activity
observed as cells progressed from S to M. Therefore, the
increased adenylate cyclase activation that can be promoted by
GTP and isoproterenol together (Fig . 3) does not reverse the
M phase-specific decline in adenylate cyclase activity . How-
ever, it was generally observed thatM phase homogenates were
more responsive to GTP, NaF, and isoproterenol, i.e ., there
was an increased ratio or index of stimulated adenylate cyclase
activity to basal activity in M phase homogenates, relative to
such ratios calculated from the S or G, phase enzyme activities
(see Table I) .
Cell Cycle Dependence of ( 3H]DHA Binding to
Membrane Preparations
The ß-adrenergic antagonist (-) [ 3H]DHA was used to char-
acterize the ,ß-adrenergic receptor as a function of the cell
cycle . [3H]DHA bound to membrane preparations from unsyn-
chronized C s cells in a manner typical of ,ß-adrenergic stimu-
lation: by use of incubation conditions identical to those used
for the adenylate cyclase assay to facilitate comparisons, the
binding was observed to be rapid and reversible . Competition
for the binding sites was stereospecific by both,ß-agonists and
,8-antagonists and in the same order ofpotency as observed for
adenylate cyclase activation (see above) . Agonist competition
was sensitive to GTP as previously reported (19, 20) but not to
NaF . The binding was also saturable asexamined by measuring
the specific binding (see Materials and Methods) of increasing
[3H]DHA concentrations to the membrane preparations. The
KD of [ 3H]DNA binding could then be determined by analyzing
these data by the methods of Scatchard (34) . Fig. 5 shows the
binding isotherm of one such experiment and the linear Scat-
chard plot generated from these data. The KD calculated from
this experiment was 1 .5 nM and the binding capacity of the
membranes equalled 0.46 pmol [3H]DHA bound/mg protein.
Hill coefficients ranging from 0.9 to 1.2 indicate that C B cell
membrane ß-receptors are neither positively nor negatively
cooperative for binding of this tracer ligand .
To determine whether changes in the ,ß-adrenergic receptor
might account for the alterations in isoproterenol-responsive
adenylate cyclase activity in S vs. M cells, we measured the KD
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FIGURE 5 Equilibrium saturation binding for [3H)DHA and the
Scatchard plot (inset) generated from these data . Various concen-
trations of [3H]DHA were incubated with the Cs membrane prep-
aration and the binding was terminated as described in Materials
and Methods . The Ko and maximal binding capacity evaluated in
this experiment are 1 .5 nM and 0.46 pmol radioligand bound/mg
protein, respectively .
and binding capacity of the,ß-adrenergic receptor sites in late
S, M, and early G, phase cell membranes by saturation binding
assays and Scatchard analysis . Table II presents the data from
two cell synchrony experiments . There was clearly no change
in the receptor KD for [3H]DHA between synchronized and
unsynchronized populations nor within those phases of cell
cycle that were examined . There was also little difference in
the membrane binding capacity for the radiolabeled antagonist
in preparations from thymidine-blocked (G,/S phase), S phase,
or mitotic cells. It is, therefore, doubtful that alterations in the
ß-receptor sites are the basis for the decreased enzyme activity
(or increase in stimulation index) observed between S and M
phase cells. The mean binding capacity did appear to increase
in early G, to a quantity roughly equal to that found in
unsynchronized (exponentially growing) cultures and may in-
dicate one mechanism by which the adenylate cyclase activity
increases upon progression from the M to G, phase . In sum-
mary, the only difference in ß-receptor sites that was detected
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Phase of cell cycle
Basal and
Basal
Stimulated Adenylate Cyclase Activities as a Function of the Cell Cycle
Adenylate cyclase specific activity
10PM GTP 10ILM (-)isoproterenol 10 mM NaF
5 25 ± 1 .5 (4) * 82 t 8.4 (4)* 186± 28 (4) * 60 t 0,8 (4)
M 3 .5 t 2.2 (4) 35 ± 3.6 (4) 86 t 11 (3) 16t 16 (4)
G, 11 ± 3 .6 (3)$ 61 ± 6 (3)* 98 t 19 (3) 35 ± 2.3 (3)
US§ 14 ± 2 (15) 41 ± 7.0 (12) 116 ± 19 (9) 48f 6.1 (34)
Fold increase over basal (stimulation index)
S 3.3 7.4 2.4
M 10.0 24 .0 4.6
G, 5.6 8.9 3.2
US 2 .9 8.3 3.4TABLE II
( 3H]DHA Binding as a Function of the Cell Cycle
The saturation binding of [3H]DHA wasdetermined at equilibrium (18 min
at 30°C) as described in Materials and Methods . Each assay was performed
on a membrane preparation with six different radioligand concentrations .
Both nonspecific and total binding were measured in triplicate . The data are
given as the mean ± SD for duplicate observations of the dissociation
constant (Ko) and the maximal bindingcapacity as determined by a Scatchard
plot .
*n=6.
in S, M, and G, phase cells was a possible increase in the
number of specific [3H]DHA-binding sites as cells completed
M and entered the G, phase .
DISCUSSION
Decreased cyclic AMP levels were found in Cs cultures en-
riched for mitotic cells using chemical synchronization meth-
ods . The lowest cyclic AMP levels invariably coincided with
the peak in MI . At a point after the majority of the cells had
completed mitosis, but still early in the G, phase, there was a
rapid increase in the cellular cyclic AMP content . The present
and previous observations (5, 26, 36, 39, 44, 45) that mamma-
lian mitotic cells contain less cyclic AMP per milligram of cell
protein than cells in interphase (i .e ., the G,, S, and GZ phase)
indicate the generality of this phenomenon.
We also examined the ability of the iß-adrenergic agonist
isoproterenol to activate the cyclic AMP synthetic enzyme
adenylate cyclase and increase the accumulation ofcyclicAMP
in whole cells. For these hormone response studies using intact
Cs cells, we chose a 2-min incubation time with isoproterenol
because during this short interval the accumulation of cyclic
AMP in unsynchronized cultures was linear, reflecting the
enzymatic rate ofcyclicAMP synthesis. Complications brought
on by the secretion of intracellular cyclic AMP in Cs cells in
response to the elevated cyclic AMP levels produced by hor-
mone stimulation could be ignored, as this phenomenon was
observed only after longer periods ofincubation with hormone
(29) . Similarly, hormonal desensitization during this period
would be negligible (8, 43) . The rate of cyclic AMP accumu-
lation in response to isoproterenol stimulation remained rela-
tively constant during the mid to late S phase and early G Z
phase but decreased as cells entered mitosis . After the mitotic
phase, as cells entered G,, the cells exhibited a significantly
enhanced responsiveness to isoproterenol. Although hormone
responsiveness increases with C6 cell density,' the cell cycle-
related changes were density independent . Moreover, in con-
trast to the previous observation that microtubule-disrupting
agents increase the cellular accumulation of cyclic AMP in
response to hormones (32), the C 6 cells i8-adrenergic hormonal
response is not significantly affected by colchicine or colcemid .
These data confirm the recent results of Gibbs et al . (12) . Thus,
the lower response of mitotic Cs cells to isoproterenol appears
to reflect a decreased capacity to synthesize cyclic AMP during
mitosis.
2 R . F. Howard and J . R . Sheppard . Unpublished observations .
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Changes in hormonal responsiveness have been previously
shown to occur during unusual physiological or pathological
conditions . For example, responsiveness to a hormone de-
creases after extended cellular exposure to that hormone, a
phenomenon known as hormonal desensitization (25) . Super-
sensitivity that occurs after an extended period of hormonal
deprivation has been associated with an increased density of
receptors . Alterations in hormone response that occur upon
neoplastic transformation (7, 22, 27, 37) may be related to the
receptor changes (38) . Other pathological states are known to
be caused by changes in hormone receptors and/or hormonal
response (9, 11, 15) .
We examined the ß-adrenergic receptor sites and adenylate
cyclase activity in synchronized C 6 cells in an attempt to
determine which component(s) of hormone-stimulated adenyl-
ate cyclase activity correlates with the decreased cyclic AMP
level in the mitotic cell . Such an undertaking, it was hoped,
might also indicate the physiologically relevant mechanism(s)
by which cells autoregulate their synthesis of cyclic AMP .
Direct binding studies using the iß-adrenergic radioligand
(-)[ 3H]DHA indicated that no change in ,ß-adrenergic recep-
tor-ligand affmity occurred during the S, M, and early G,
phases . Receptor density did not differ in S and M phase
membranes but increased in early G, relative to S andM phase
cells, suggesting that iß-adrenergic hormone binding sites are
maintained at a constant density in the C6 plasma membrane,
just as total cellular protein increases linearly with the cell
cycle (31) .
The mean specific activity of adenylate cyclase was lower in
membrane preparations from mitotic cells than from either S
phase or early G, phase cells . This was generally true regardless
of whether the enzyme activity was assayed in the absence or
presence of GTP, fluoride, or isoproterenol (Table I) . These
changes are consistent with the reduced cyclicAMP levels and
the reduced rate of accumulation ofcyclic AMP in response to
isoproterenol that were observed in whole mitotic Ce cells .
They also confirm earlier reports (14, 26, 28) which indicated
that the adenylate cyclase activity of mitotic cells is less than
the activity in S or G, phase cells, in contrast to one other
report (23) . The more or less uniform decrease that we observed
in the cyclase activity of mitotic cells as well as the subsequent
increase in the G, enzyme activity are interesting in light ofthe
data (e.g ., reference 21, and our Figs . 3 and 4) that each of
these adenylate cyclase effector molecules (GTP, NaF, hor-
mone) acts by separate mechanisms to increase the C s cell's
enzyme activity. Moreover, we found no evidence for an un-
equal distribution of soluble cytoplasmic substances (e.g., cal-
modulin) within different phases of the cell cycle (as assayed
on sucrose gradient-purified C 6 cell membranes) which could
account for the phase-specific changes in cyclase activity .'
A most unexpected observation was that, while both the
basal and effector-stimulated adenylate cyclase activities de-
creased during mitosis relative to the S phase and G, phase
activity, the adenylate cyclase stimulation index (stimulated
cyclase activity/basal activity) increased in mitotic cells relative
to the S or G, phases. Thus, although the basal activity
decreased during mitosis, the three enzyme activators (GTP,
NaF, and isoproterenol) increased the basal adenylate cyclase
activity more efficiently during this phase of the cell cycle.
This paper further substantiates that the plasma membrane
of the mitotic cell is functionally altered (1) . Structural changes
in the membrane have previously been reported in G 2 (41, 42)
and mitosis (10, 18, 30) . We also observed a quantitative
Phase of cell cycle Ko
nM
Binding capacity
pmol specifically
boundlmg protein
G, /S 1 .3 0.23
Mid to late S 1 .6 ± 0.3 0.27 ± 0.02
M 1.4±0 0.28±0.06
G, 1 .4 0.36
Unsynchronized* 1 .4 ± 0.5 0.38± 0.05change, but no qualitative changes, in the membrane-associ-
ated ß-adrenergic receptor as cells completed mitosis and en-
tered the GI phase . This may be partially responsible for the
increased hormone responsiveness of the GI phase cell . The
molecular mechanisms leading to the decreased absolute cy-
clase activity and the apparent increase in coupling efficiency
of the adenylate cyclase in mitoticC6 cellsmayinvolvechanges
in the G/F (21) or N (6, 17) protein which is required for the
stimulation of enzyme activity. This protein and/or the intrin-
sic catalytic component of the adenylate cyclase membrane
complex could be affected by the dynamic physiological
changes occurring in the mitotic cell . While the biological
importance of this change in membrane function is currently
unclear, the decreased basal and stimulated adenylate cyclase
specific activities during mitosis could conceivably reflect a
relationship between cyclic AMP metabolism and cytoskeletal
organization (24, 32, 33, 40) .
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